Product
Ranibizumab
Aliases
0.5 mg ranibizumab, Lucentis, Ranibizumab 10mg/ml Injection, Ranibizumab Injection [Lucentis] (1 other aliases)
30 clinical trials
26 indications
Indication
Age-Related Macular DegenerationIndication
Diabetic Macular EdemaIndication
Diabetic RetinopathyIndication
Macular EdemaIndication
Retinal DiseaseIndication
retinal degenerationIndication
Pathologic MyopiaIndication
Age-related macular degenerationIndication
nAMDIndication
Age-related Macular DegenerationIndication
wAMDIndication
Wet AMDIndication
CNVIndication
Retinal Vein OcclusionIndication
Retinopathy of PrematurityIndication
Diabetic Macular OedemaIndication
Subfoveal Choroidal NeovascularizationIndication
DiabetesIndication
Age Related Macular DegenerationIndication
Retina DiseaseIndication
RanibizumabIndication
Macular IschemiaIndication
VEGF OverexpressionClinical trial
A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination With Ranibizumab, Compared With Ranibizumab Alone, in Participants With nAMDStatus: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
A Phase IIIb, Multicenter, Randomized, Visual Assessor-Masked Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular DegenerationStatus: Withdrawn, Estimated PCD: 2025-01-31
Clinical trial
A Phase II, Multicenter, Randomized, Double Masked, Active Comparator-Controlled Study to Investigate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients With Diabetic Macular EdemaStatus: Active (not recruiting), Estimated PCD: 2024-10-03
Clinical trial
Randomized, Double-blind, Parallel, Active Controlled Study to Compare Efficacy & Safety Between Ranibizumab 10mg/ml Injection of Incepta and Lucentis in Patients With Diabetic Macular Edema by ITV InjectionStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Choroidal Neovascularization Secondary to Pathologic MyopiaStatus: Recruiting, Estimated PCD: 2026-02-02
Clinical trial
A Phase IIIb, Global, Multicenter, Randomized, Visual Assessor-Masked Study Of The Efficacy, Safety, And Pharmacokinetics Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab In Patients With Neovascular Age-Related Macular Degeneration (Velodrome)Status: Recruiting, Estimated PCD: 2026-12-31
Clinical trial
A Phase II, Multicenter, Randomized, Double Masked, Active Comparator-Controlled Study to Investigate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7200220 in Combination With Ranibizumab Administered Intravitreally in Patients With Diabetic Macular EdemaStatus: Active (not recruiting), Estimated PCD: 2024-04-17
Clinical trial
A Randomized, Partially Masked, Controlled, Phase 2b/3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants With nAMD (ATMOSPHERE)Status: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
A Three-Part, Phase I Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Zifibancimig Following Intravitreal Administration of Multiple Ascending Doses and Continuous Delivery From the Port Delivery in Patients With Neovascular Age-Related Macular DegenerationStatus: Recruiting, Estimated PCD: 2026-02-09
Clinical trial
A Phase III, Multicenter, Randomized, Visual Assessor-Masked, Active Comparator Study Of The Efficacy, Safety, And Pharmacokinetics Of The Port Delivery System With Ranibizumab In Chinese Patients With Neovascular Age-Related Macular DegenerationStatus: Recruiting, Estimated PCD: 2027-02-25
Clinical trial
A Phase III, Multicenter, Randomized, Visual Assessor-Masked, Active-comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Diabetic Macular Edema (Pagoda)Status: Active (not recruiting), Estimated PCD: 2022-09-19
Clinical trial
A Randomized, Double Masked, Multicenter, Phase III Study Assessing the Efficacy and Safety of 601 Versus Ranibizumab in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)Status: Recruiting, Estimated PCD: 2025-12-01
Clinical trial
RAINBOW Extension Study: an Extension Study to Evaluate the Long Term Efficacy and Safety of RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of PrematurityStatus: Completed, Estimated PCD: 2022-04-21
Clinical trial
A Phase III, Multicenter, Randomized, Double-Masked, Parallel Controlled, Non Inferior Study to Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection With Ranibizumab in Subjects With Wet Age-related Macular Degeneration (wAMD)Status: Recruiting, Estimated PCD: 2025-07-31
Clinical trial
A Phase III Double-Blind, Parallel Group, Multicenter Study to Compare the Efficacy and Safety of Xlucane Versus Lucentis® in Patients With Neovascular Age-Related Macular DegenerationStatus: Completed, Estimated PCD: 2021-05-11
Clinical trial
Phase III, Multicenter, Randomized, Visual Assessor-Masked, Active-Comparator Study of the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular DegenerationStatus: Completed, Estimated PCD: 2020-05-22
Clinical trial
A Phase 2, Randomized, Dose-escalation, Ranibizumab-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of RGX-314 Gene Therapy Delivered Via One or Two Suprachoroidal Space (SCS) Injections in Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE)Status: Recruiting, Estimated PCD: 2023-10-01
Clinical trial
Noctura400 Treatment for Diabetic Retinopathy: Pilot Study to Demonstrate and Evaluate the Care Pathway for National Health Service (NHS) AdoptionStatus: Terminated, Estimated PCD: 2023-08-01
Clinical trial
Randomized, Double Blind, Controlled Study With Verteporfin Photodynamic Therapy And Intravitreal Triamcinolone(IVTA) Vs Triple Therapy With Verteporfin Photodynamic Therapy, Intravitreal Triamcinolone And Intravitreal Ranibizumab In Patients With Subfoveal Choroidal Neovascularization(CNV) Secondary To Age-related Macular Degeneration(AMD)Status: Withdrawn, Estimated PCD: 2006-04-01
Clinical trial
Combined Anti-VEGF Intravitreal Injections With Sustained Steroid Implantation for the Treatment of Diabetic Macular OedemaStatus: Withdrawn, Estimated PCD: 2022-09-01
Clinical trial
Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor AgentsStatus: Recruiting, Estimated PCD: 2024-06-14
Clinical trial
Evaluation Of the Safety, Tolerability and Efficacy of Ranibizumab and Tocilizumab in Eyes With Diabetic Macular Edema.Status: Withdrawn, Estimated PCD: 2016-10-05
Clinical trial
OCTA-Directed PDT Triple Therapy for Treatment-Naïve Patients With Exudative Age-Related Macular Degeneration Versus Standard of Care Anti-VEGF(Anti-vascular Endothelial Growth Factor) MonotherapyStatus: Withdrawn, Estimated PCD: 2024-11-01
Clinical trial
Long-term Need of Ranibizumab Injections With or Without Early Targeted Peripheral Laser Photocoagulation for Treatment of Macular Edema Due to Central Retinal Vein OcclusionStatus: Recruiting, Estimated PCD: 2025-07-30
Clinical trial
Traditional Chinese Medicine and Ranibizumab in the Treatment of Macular Cystoid Edema Associated With Retinal Vein Obstruction.Status: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein OcclusionStatus: Recruiting, Estimated PCD: 2024-10-30
Clinical trial
Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time Optical Coherence Tomography During OperationStatus: Recruiting, Estimated PCD: 2023-12-01
Clinical trial
Comparative Study Between Intravitreal Injection of Ranibizumab With and Without Prior Anterior Chamber Paracentesis in Patients With Diabetic Macular Oedema Using Optical Coherence Tomography Angiography [OCT-A]Status: Recruiting, Estimated PCD: 2024-04-01
Clinical trial
Intravitreal Ranibizumab Injection In Aggressive Retinopathy Of Prematurity Compared With Type 1 Prethreshold Retinopathy Of PrematurityStatus: Completed, Estimated PCD: 2022-11-20
Clinical trial
Comparison of the Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema Using OCTAStatus: Terminated, Estimated PCD: 2022-09-01